Yoshiki Kuwabara Selected Research

Neoplasms (Cancer)

8/2021	Initial rapidity of tumor growth as a prognostic factor for the therapeutic effect of immune-checkpoint inhibitors in patients with non-small cell lung cancer: evaluation for linear and non-linear correlation.
1/2021	Functional inhibition of heat shock protein 70 by VER-155008 suppresses pleural mesothelioma cell proliferation via an autophagy mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiki Kuwabara Research Topics

Disease

2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 08/2021
2	Neoplasms (Cancer) 08/2021 - 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Brain Neoplasms (Brain Tumor) 11/2023
1	Mesothelioma 01/2021
1	Starvation 01/2021
1	Type IV Ehlers-Danlos Syndrome 12/2019

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2019
1	Therapeutic UsesIBA 08/2021
1	Immune Checkpoint InhibitorsIBA 08/2021
1	VER 155008IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	AsbestosIBA 01/2021
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Collagen Type III (Type III Collagen)IBA 12/2019

Therapy/Procedure

2	Therapeutics 11/2023 - 01/2021
1	Craniotomy 11/2023
1	Combined Modality Therapy 11/2023
1	Drug Therapy (Chemotherapy) 11/2023
1	Radiotherapy 11/2023